Metlifecare Upgrade (MET NZX)

18 April 2020

In our Healthcare theme MET plays an important role. We are re-instating a buy rating @ $4.05 mark as this high quality stock is trading well below its NTA of $7.

Do You Want Daily Market Insights?

If you’re interested in staying up-to-date with the latest news and analysis on stocks, be sure to sign up to BlackBull Research.

1 Month Free Trial

Access our expert stock market research Free of charge with no obligation

Free 1 Month Free Trial

Unlock this article & access our expert stock market research

ASX, NZX & USD Stock Buy, Hold, Sell recommendations. Model Portfolios. Daily news and more